Labs / Assays & in vitro testing
Axolabs
Kulmbach, Germany · axolabs.com
GLP · GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Axolabs provides CRO and CDMO services for nucleic acid therapeutics, including oligonucleotides and RNA modalities. It works from sites in Petaluma, USA, and Berlin and supports projects from discovery and preclinical work through GMP manufacturing and clinical supply.
Their website has a general contact form; we send your quote request through it.
What they offer
In silico & bioinformatics
Uses proprietary algorithms and sequence modeling to predict off-target interactions and support rational lead selection before benchwork begins.
Rational design & synthesis
Performs chemical modification and solid-phase synthesis to improve oligonucleotide stability, reduce immunogenicity, and enable targeted delivery.
Preclinical screening
Evaluates oligonucleotide libraries with automated synthesis, rapid purification, and multiplexed assays for efficacy, specificity, and safety.
Cell-based evaluations
Uses in vitro platforms to assess on-target effects, cytotoxicity, and immunostimulation for early go/no-go decisions.
Advanced bioanalytics
Applies proprietary PNA-HPLC, LC-MS/MS, and cytokine profiling to study kinetics, biodistribution, metabolism, and immune responses.
mRNA analytics
Provides analytical characterization and bioanalytical support for mRNA therapeutics and vaccines, including critical quality attributes and pharmacology studies.
LNP Formulation Services
Offers LNP formulation and characterization support for RNA therapeutics.
Early-stage oligonucleotide synthesis & lead optimisation
Provides high-throughput early-stage synthesis for multiple RNA modalities using 96-well platforms and conjugation chemistry for ligand modifications.
Large-scale oligonucleotide manufacturing
Delivers pilot to commercial scale manufacturing of oligonucleotides using Cytiva and AKB THESYS platforms.
cGMP production
Provides dual-site cGMP manufacturing for oligonucleotide therapeutics for clinical and initial commercial supply.
GMP analytics & quality control
Supports manufacturing with analytical QC and release testing using chromatographic and LC-MS methods.
Integrated technology transfer
Coordinates transfer from discovery and pilot scale into scalable CDMO and GMP manufacturing workflows.
What they work on
- Modalities
- ADC, Oligonucleotide, mRNA, Recombinant protein, Vaccine, LNP / formulation
- Assays and studies
- RNA-Seq-based off-target analysis, LC-MS/MS, PNA assay, cell-based functional testing, Quantigene™, qPCR, RNA-Seq, xCELLigence®, flow cytometry, PNA-HPLC, cytokine profiling, uHPLC, and 3 more
- Instruments and platforms
- Cytiva OligoPilot™, Cytiva OligoProcess™, Asahi Kasei Bioprocess (AKB THESYS™), AKB THESYS™ Synth100, AKB THESYS™ Synth1500, xCELLigence®
- Scale and capacity
- 96-well platforms, up to 300 mmol batch capacity, milligram to kilogram batches, dual-site cGMP manufacturing
- What to send
- Synthesis request form (.xlsx) to be completed and sent to orders@axolabs.com
- Type
- CRDMO
- Sites
- Petaluma, USA · Berlin, Germany · Kulmbach, Germany
- Quality
- GLP (bioanalysis) · GMP (manufacturing and compliance) · GLP/GCP (bioanalysis and pharmacology studies)
- Serves
- global
- Address
- 2000 Dr Roland Kreutzer and Dr Stefan Limmer founded Ribopharma AG, the first
- Founded
- 2000
Public records
Similar labs. Integral BioSystems, Hope Medicine (HopeMed), JPT Peptide Technologies, Transcenta Holding
Found in the German GLP list (BfR). Listing built from axolabs.com. Work here? Claim this listing.